SynCardia Systems, Inc.06/13/2013
Getting to the Destination: Dr. Marvin Slepian, SynCardia
Marvin J. Slepian, M.D.Co-Founder, Chief Scientific and Medical Officer,
Science Advisory Board Chairman
Fireside Chat – Bill Burkoth – Pfizer Ventures
Bill Burkoth is currently an Executive Director of Pfizer
Ventures, the venture capital arm of Pfizer Inc. Since joining Pfizer in early
2004, Bill has played an instrumental role in numerous new venture capital
investments, including Avid Radiopharmaceuticals (acquired by Eli Lilly),
Clovis Oncology (Nasdaq: CLVS), DVS Sciences
(acquired by Fluidigm), Evolution Benefits (acquired by Genstar Capital),
HandyLab (acquired by Becton Dickinson), and HD Biosciences (acquired by Wuxi
AppTec). Bill currently serves on the board of directors of AMRA,
Biodesy, DIR Technologies, G-Con Manufacturing, NeuMoDx Molecular, Novocure
(Nasdaq: NVCR), Palleon Pharma, RefleXion Medical, and Strata Oncology.
He is also a member of the investment committee of the Investment Fund for
Health in Africa (IFHA) and FinHealth Gestão de Recursos S.A. (Rio,
Prior to joining Pfizer, Bill worked in Business Development
at Galileo Pharmaceuticals and at IntraBiotics Pharmaceuticals. Prior to his
roles in business development, Bill was an analyst at Bay City Capital. Mr.
Burkoth received a BA in chemistry from Whitman College and an MBA from
Columbia Business School.
White Hat Opening Keynote with Greg Carlisle, Warren Investments & Family Office Panel
Patient Driven Innovation and Investing
Crawford is the Founder and Executive Director of Focus on Lyme and leads the
team in achieving its mission to improve diagnostics, treatment, prevention,
and advocacy for patients suffering from Lyme and associated tick-borne disease. Tammy was inspired to create Focus on Lyme by
her daughter Jessica’s journey and is motivated every day to try to ensure no
one has to experience what she did.
Leadership Conversation with Nobel Laureate Leland Hartwell, PhD (2014)
How will we create sustainable health? What innovations can make a difference? What is the role of education? Lee Hartwell, PhD, is the Virginia G. Piper Chair in Personalized Medicine at the Center for Sustainable Health, Biodesign Institute, Arizona State University. At the Center his work focuses on creating effective learning environments. The first is a course required for all K-8 teachers, Sustainability Science for Teachers and the second is Project Honey Bee, an interdisciplinary research project to validate wearable devices for ambulatory patient management. He also oversees a project to develop biomarkers for the clinical management of many diseases at the Chang Gung Memorial Hospital and University in Taipei, Taiwan. Dr. Hartwell was awarded the 2001 Nobel Prize in Physiology or Medicine for identifying genes that control cell division in yeast.
Panel: Bridging the Funding Gap
As AZBio celebrates its 10th anniversary as Arizona's statewide bioindustry association, AZBio President and CEO Joan Koerber-Walker calls on the community to do what it does best - embrace possibilities and come together to build something amazing.
Calimmune - A case study from the innovator and investor perspective
AZBio Awards Highlights 2011
AZBio CEO, Joan Koerber-Walker shares highlights from the 2011 AZBio Awards. Meet some of this year's award winners.